Table 4 Diagnostic performance and characteristics of COVID-19 Life Events—Anxiety Inventory
Categories | N | AUC | SE | p value | 95% CI | Cut off | |
Total cases | 500 | 0.826 | 0.038 | <0.001* | 0.752−0.901 | ≥49.0 | |
Gender | Male | 182 | 0.886 | 0.047 | <0.001* | 0.795−0.977 | ≥49.0 |
Female | 318 | 0.797 | 0.054 | <0.001* | 0.691−0.902 | ≥47.0 | |
Diagnostic characteristics | |||||||
Characters | Male ≥49.0 | Female ≥47.0 | Both together Male ≥49.0 Female ≥47.0 | ||||
Value | 95% CI | Value | 95% CI | Value | 95% CI | ||
Sensitivity | 68.4% | 60.9%–75.2% | 76.6% | 71.4%–81.3% | 73.6% | 69.4%–77.5% | |
Specificity | 100% | 63.1%–100% | 78.9% | 54.4%–93.9% | 85.2% | 66.3%–95.8% | |
DA | 69.8% | 62.5%–76.4% | 76.7% | 71.7%–81.3% | 74.2% | 70.1%–78.0% | |
YI | 68.4% | 61.5%–75.3% | 55.5% | 36.6%–74.5% | 58.8% | 44.8%–72.7% | |
PPV | 100% | 96.9%–100% | 98.3% | 95.7%–99.5% | 98.9% | 97.1%–99.7% | |
NPV | 12.7% | 5.6%–23.5% | 17.6% | 10.2%–27.4% | 15.5% | 10.1%–22.4% | |
LR+ | >100.0 | >100–>100 | 3.64 | 1.52–8.71 | 4.97 | 2.01–12.29 | |
LR- | 0.32 | 0.25–0.39 | 0.30 | 0.22–0.40 | 0.31 | 0.25–0.39 | |
LR | >100.0 | >100–>100 | 12.27 | 3.94–38.17 | 16.01 | 5.43–47.20 | |
Kappa | 0.160 | 0.059–0.260 | 0.211 | 0.107–0.316 | 0.189 | 0.114–0.263 | |